Tandem Diabetes Care Announces First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Tandem Diabetes (TNDM) Misses Q1 EPS by 8c, Revenues Beat; Provides 2Q Revenue Outlook, Withdraws FY20 Guidance
April 30, 2020 4:51 PM EDTTandem Diabetes (NASDAQ: TNDM) reported Q1 EPS of ($0.25), $0.08 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $97.9 million versus the consensus estimate of $84.46 million.
In comparing the first quarter of 2020 to the same period of 2019:
Worldwide pump shipments increased 18 percent to 17,378 pumps from 14,732 pumpsSales increased 48 percent to $97.9 million from $66.0 millionGross margin for both... More
